Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/2006

Content (16 Articles)

Epidemiology

IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH–DNA adducts to breast cancer risk

Jing Shen, Mary Beth Terry, Marilie D. Gammon, Mia M. Gaudet, Susan L. Teitelbaum, Sybil M. Eng, Sharon K. Sagiv, Alfred I. Neugut, Regina M. Santella

Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients

Sarah Park, Chikako Shimizu, Tatsu Shimoyama, Masayuki Takeda, Masashi Ando, Tsutomu Kohno, Noriyuki Katsumata, Yoon-Koo Kang, Kazuto Nishio, Yasuhiro Fujiwara

Prediction of breast cancer using volatile biomarkers in the breath

Michael Phillips, Renee N. Cataneo, Beth Ann Ditkoff, Peter Fisher, Joel Greenberg, Ratnasiri Gunawardena, C. Stephan Kwon, Olaf Tietje, Cynthia Wong

Preclinical study

Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells

Abde M. Abukhdeir, Brian G. Blair, Keith Brenner, Bedri Karakas, Hiroyuki Konishi, Joselin Lim, Vanita Sahasranaman, Yi Huang, Judith Keen, Nancy Davidson, Michele I. Vitolo, Kurtis E. Bachman, Ben Ho Park

Epidemiology

Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer

Bette J. Caan, Jennifer A. Emond, Loki Natarajan, Adrienne Castillo, Erica P. Gunderson, Laurel Habel, Lovell Jones, Vicky A. Newman, Cheryl L. Rock, Martha L. Slattery, Marcia L. Stefanick, Barbara Sternfeld, Cynthia A. Thomson, John P. Pierce

Epidemiology

Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene

Bartłomiej Masojć, Marek Mierzejewski, Cezary Cybulski, Thierry van de Wetering, Tadeusz Dębniak, Bohdan Górski, Ewa Jaworowska, Czesława Tarnowska, Marcin Lenner, Rodney J Scott, Jan Lubiński

Clinical trial

Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients

Nan Soon Wong, Harriette J. Kahn, Liying Zhang, Stephanie Oldfield, Lu-Ying Yang, Alexander Marks, Maureen E. Trudeau

Epidemiology

BRCA1-positive breast cancers in young women from Poland

J. Lubiński, B. Górski, T. Huzarski, T. Byrski, J. Gronwald, P. Serrano-Fernández, W. Domagała, M. Chosia, M. Uciński, E. Grzybowska, D. Lange, B. Mąka, A. Mackiewicz, A. Karczewska, J. Bręborowicz, K. Lamperska, M. Stawicka, S. Gozdecka-Grodecka, M. Bębenek, D. Sorokin, A. Wojnar, O. Haus, J. Sir, T. Mierzwa, S. Niepsuj, K. Gugała, S. Góźdź, J. Sygut, B. Kozak-Klonowska, B. Musiatowicz, M. Posmyk, R. Kordek, M. Morawiec, O. Zambrano, B. Waśko, L. Fudali, J. Skręt, D. Surdyka, K. Urbański, J. Mituś, J. Ryś, M. Szwiec, A. Rozmiarek, I. Dziuba, P. Wandzel, R. Wiśniowski, C. Szczylik, A. Kozak, W. Kozłowski, S.A. Narod

Clinical trial

Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer

Alessandro Neri, Daniele Marrelli, Franco Roviello, Giovanni De Marco, Federico Mariani, Alfonso De Stefano, Tiziana Megha, Stefano Caruso, Gianni Corso, Tommaso Cioppa, Enrico Pinto

Clinical trial

Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer

Socorro María Rodríguez Pinilla, Emiliano Honrado, David Hardisson, Javier Benítez, José Palacios

Preclinical study

Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines

Marijke Wasielewski, Fons Elstrodt, Jan G.M. Klijn, Els M.J.J. Berns, Mieke Schutte

Preclinical study

Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier

Cheryl M. Lewis, Brittney-Shea Herbert, Dawei Bu, Shane Halloway, Adam Beck, Ashleen Shadeo, Cindy Zhang, Raheela Ashfaq, Jerry W. Shay, David M. Euhus

Letter to the Editor

Optical coherence tomography in tamoxifen retinopathy

Mauget-Faÿsse Martine, Gambrelle Joël, Quaranta-El Maftouhi Maddalena

Erratum

Optical coherence tomography in tamoxifen retinopathy

Mauget-Faÿsse Martine, Gambrelle Joël, Quaranta-El Maftouhi Maddalena

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine